Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Cantor 2020 Global Virtual Healthcare Conference Call Transcript

Why Inovio Pharmaceuticals Is Losing Steam Today

10:36am, Thursday, 17'th Sep 2020
A noted Inovio bear weighs in on the stock's strong showing this week.
Curious why INO stock jumped in recent trading? Overall optimism wasn't the only reason.
The Global Electroporation Instruments Market will grow by USD 72.67 mn during 2020-2024

Why Inovio Stock Is Soaring Again Today

11:32am, Wednesday, 16'th Sep 2020
Investors remain enthusiastic about comments made earlier this week by Inovio's CEO.
Inovio Pharmaceuticals teased investors on Monday that Phase 1 results were just around the corner. INO stock is still rallying.
Shares of coronavirus stock Inovio Pharmaceuticals (INO) surged again on Tuesday. INO was up about 18% in late-morning trading and ended the trading day up 20.4% to $13.63.
Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine for the novel coronavirus, are on a strong three-day run.
Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market Bubbles
Inovio's shares are on the mend today.
Each of these biotech stocks has more than tripled year to date and could still have plenty of room to run.
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Ino
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at H.C.
Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.
INO stock has pulled back some 72% from its highs. But the fade makes sense, and even at a cheaper price the stock still looks like an avoid.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE